Reduction in CRP 1 year after initiation compared to 1 year prior to GLP-1RA initiation (12.92 vs 6.38 mg/dL, P = .005) with correlation between weight and CRP post-GLP-1RA therapyNo statistically significant difference in the number of IBD-related hospitalizations, clinical rating scores, or endoscopic scores between the years before and after GLP-1RA initiation. The gene discussed is CRP; the disease is inflammatory bowel disease.